Abstract
The development of transcriptionally controlled systems which function in eukaryotic cells are important for achieving regulated gene expression in gene therapy. In this study we combined the components of the tetracycline-inducible system in self-contained retroviral and plasmid vectors. Regulated reporter gene expression from the autoregulatory plasmid pGTRTL in response to doxycycline (Dox) induction surpasses the expression observed from other self-contained retroviral and plasmid vectors. Induction kinetics and expression levels of luciferase and the therapeutic molecule, truncated soluble complement receptor 1 (sCR1) were characterised in a mouse fibroblast and a human neuroblastoma cell line. The regulatory characteristics of the plasmids were shown to be optimal for gene therapy applications, as there was a rapid reduction in expression levels following removal of Dox. Co-transfection of cells with an autoregulatory plasmid and a Dox inducible enhanced green fluorescent protein (EGFP) plasmid demonstrated the feasibility of using this plasmid combination to achieve parallel regulation of two genes of interest in a single cell under the control of Dox. These novel autoregulatory plasmids display the requirements for gene therapy applications in chronic conditions which are remitting/relapsing such as rheumatoid arthritis or multiple sclerosis, where novel protein therapeutics and combination therapies are needed.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Gossen M, Bujard H . Tight control of gene expression in mammalian cells by tetracycline-responsive promotors Proc Natl Acad Sci USA 1992 89: 5547–5551
Paulus W et al. Self-contained, tetracycline-regulated retroviral vector system for gene delivery to mammalian cells J Virol 1996 70: 62–67
Lindermann D, Patriquin E, Feng S, Mulligan RC . Versatile retrovirus vector systems for regulated gene expression in vitro and in vivo Mol Med 1997 3: 466–476
A-Mohammadi S, Hawkins RE . Efficient transgene regulation from a single tetracycline-controlled positive feedback regulatory system Gene Therapy 1998 5: 76–84
Shockett P, Difilippantonio M, Hellman N, Schatz DG . A modified tetracycline-regulated system provides autoregulatory, inducible expression in cultured cells and transgenic mice Proc Natl Acad Sci USA 1995 92: 6522–6526
Hofmann A, Nolan GP, Blau HM . Rapid retroviral delivery of tetracycline-inducible genes in a single autoregulatory cassette Proc Natl Acad Sci USA 1996 93: 5185–5190
Gossen M et al. Transcriptional activation by tetracyclines in mammalian cells Science 1995 268: 1766–1769
Zeng Q, Tan YH, Hong W . A single plasmid vector (pSTAR) mediating efficient tetracycline-induced gene expression Anal Biochem 1998 259: 187–194
Watsuji T et al. Controlled gene expression with a reverse tetracycline-regulated retroviral vector (RTRV) system Biochem Biophys Res Com 1997 234: 769–773
Strathdee CA, McLeod MR, Hall JR . Efficient control of tetracycline-responsive gene expression from an autoregulated bi-directional expression vector Gene 1999 229: 21–29
Byun J et al. Analysis of the relative level of gene expression from different retroviral vectors used for gene therapy Gene Therapy 1996 3: 780–788
Carswell S, Alwine JC . Efficiency of utilization of the simian virus 40 late polyadenylation site: effects of upstream sequences Mol Cell Biol 1989 9: 4248–4258
Ryan ME, Greenwald RA, Golub LM . Potential of tetracyclines to modify cartilage breakdown in osteoarthritis Curr Opin Rheumatol 1996 8: 238–247
Smith GN, Mickler EA, Hasty KA, Brandt KD . Specificity of inhibition of matrix metolloproteinase activity by doxycycline: relationship to enzyme structure Arthritis Rheum 1999 42: 1140–1146
Amin AR et al. Post-transcriptional regulation of inducible nitric oxide synthase mRNA in murine macrophages by doxycycline and chemically modified tetracyclines FEBS Lett 1997 410: 259–264
Sewell KL et al. The effect of minocycline in rat models of inflammatory arthritis: correlation of arthritis suppression with enhanced T cell calcium flux Cell Immunol 1996 167: 195–204
Rippe K, von Hippel PH, Langowski J . Action at distance: DNA-looping and initiation of transcription Trends Biochem Sci 1995 20: 500–506
Freundlieb S, Schirra-Müller C, Bujard H . A tetracycline controlled activation/repression system with increased potential for gene transfer into mammalian cells J Gene Med 1999 1: 4–12
Jainchill JL, Aaronson SA, Todaro GJ . Murine sarcoma and leukemia viruses: assay using clonal lines of contact-inhibited mouse cells J Virol 1969 4: 549–553
Triantaphyllopoulos KA, Croxford JL, Baker D, Chernajovsky Y . Cloning and expression of murine IFNβ and a TNF antagonist for gene therapy of experimental allergic encephalomyelitis Gene Therapy 1998 5: 253–263
Weisman HF et al. Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis Science 1990 249: 146–151
Dreja H, Annenkov A, Chernajovsky Y . sCR1 (CD35) delivered by retrovirally infected syngeneic cells or by naked DNA injection prevents the progression of collagen-induced arthritis Arthritis Rheum 2000 43: 1698–1709
Saitoh Y et al. Dose-dependent doxycycline-mediated adrenocorticotropic hormone secretion from encapsulated tet-on propiomelanocortin Neuro2A cells in the subarachnoid space Hum Gene Ther 1998 9: 997–1002
A-Mohammadi S, Alvarez-Vallina L, Ashworth LJ, Hawkins RE . Delay in resumption of the activity of tetracycline-regulatable promoter following removal of tetracycline analogues Gene Therapy 1997 4: 993–997
Gallia GL, Khalili K . Evaluation of an autoregulatory tetracycline regulated system Oncogene 1998 16: 1879–1884
Corlett JE, Myatt SC, Thompson AJ . Toxicity symptoms caused by high expression of tet repressor in tomato (lycopersicon esculentun Mill. L.) are alleviated by tetracycline Plant Cell Environment 1996 19: 447–454
Stripecke R et al. Immune response to green fluorescent protein: implications for gene therapy Gene Therapy 1999 6: 1305–1312
Baron U, Freundlieb S, Gossen M, Bujard H . Co-regulation of two gene activities by tetracycline via a bidirectional promotor Nucl Acids Res 1995 17: 3605–3606
Annenkov A, Chernajovsky Y . Engineering mouse T lymphocytes specific to type II collagen by transduction with a chimeric receptor consisting of a single chain Fv and TCRζ Gene Therapy 2000 7: 714–722
Sambrook J, Fritsch EF, Maniatis T . Molecular Cloning: A Laboratory Manual Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY, USA 1989
Chernajovsky Y, Kirby-Saunders H . A cis-acting sequence, located at −450 in the promoter of the human interferon-inducible gene 6-16, binds constitutively to a nuclear protein and decreases the expression of a reporter interferon-inducible promoter Lymph Res 1990 9: 199–212
Southern PJ, Berg P . Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter J Mol Appl Genet 1982 1: 327–341
Acknowledgements
The Wellcome Trust UK, The Arthritis Research Campaign UK, The British Council and Fundacion Antorchas (Argentina) provided financial support for this work. We are grateful to Professor H Bujard for providing the tetracycline plasmids pUHG17–1, pUHD10–3 and pUHC13–3; to Professor D Fearon for providing both mAb YZ1 and control sCR1, and to Dr R Smith for supplying sCR1 rabbit antisera.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gould, D., Berenstein, M., Dreja, H. et al. A novel doxycycline inducible autoregulatory plasmid which displays ‘on’/‘off’ regulation suited to gene therapy applications. Gene Ther 7, 2061–2070 (2000). https://doi.org/10.1038/sj.gt.3301354
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3301354
Keywords
This article is cited by
-
A novel hybrid promoter responsive to pathophysiological and pharmacological regulation
Journal of Molecular Medicine (2012)
-
Stringent and reproducible tetracycline-regulated transgene expression by site-specific insertion at chromosomal loci with pre-characterised induction characteristics
BMC Molecular Biology (2007)
-
Gene therapy for autoimmune diseases: quo vadis?
Nature Reviews Immunology (2004)
-
Inhibition of established collagen-induced arthritis with a tumour necrosis factor-α inhibitor expressed from a self-contained doxycycline regulated plasmid
Arthritis Res Ther (2003)
-
Vectors for the treatment of autoimmune disease
Gene Therapy (2003)